PursueCare
PursueCare is a privately held telehealth provider founded in 2019 that delivers virtual substance use disorder and co-occurring mental health treatment, including medication-assisted treatment, in-house specialty pharmacy, and FDA-authorized digital therapeutics, to patients across six U.S. states.
- Company typePrivate
- Founded2019
- HeadquartersMiddletown, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What PursueCare does
PursueCare (legal entity PAI Delaware Holding Company, Inc., Delaware-incorporated) is a privately held telehealth provider founded in 2019 and headquartered in Middletown, Connecticut, delivering virtual substance use disorder and co-occurring mental health treatment to patients across six states (Connecticut, Kentucky, Maine, New Hampshire, Ohio, and West Virginia). The core offering is a mobile-app-enabled telehealth platform that provides same-day virtual admissions, medication-assisted treatment with FDA-approved agents (Suboxone, Sublocade, Brixadi, naltrexone), counseling, psychiatry, and case management. The company operates PursueCareRx, an in-house specialty pharmacy that dispenses addiction and mental health medications directly to patients' doors, accepting Medicare, Medicaid, and major private insurance. In August 2024, PursueCare acquired and relaunched reSET and reSET-O, FDA-authorized prescription digital therapeutics for SUD and OUD respectively, from Pear Therapeutics' bankruptcy estate, adding structured CBT modules and contingency management rewards as adjuncts to clinical care.
The business model combines insurance-billed clinical services with two productized recurring revenue streams: a $90 per 12-week subscription for reSET/reSET-O (with a financial hardship rebate program) and pharmacy revenue from in-house dispensing. Go-to-market is sales-led with both direct-to-patient intake and a B2B referral motion targeting health systems, emergency departments, primary care practices, health plans, and higher education institutions; named partners include OhioHealth and Operation Unite, with reported 74% referral-to-treatment conversion. PursueCare differentiates on regulatory and integration moats (Joint Commission accreditation, HIPAA and 42 CFR Part 2 compliance, LegitScript verification, FDA-authorized PDTs, and vertically integrated clinical-plus-pharmacy delivery) and reports strong clinical outcomes including 75% patient retention, 85% substance use reduction, and 1% in-treatment re-hospitalization. The company has raised approximately $12.75M in disclosed equity funding across seed, Series A, and Series B rounds between 2019 and 2021, led by Seyen Capital, OCA Ventures, Wasabi Ventures, Starboard Capital Partners, and WRD Capital, with founder Nicholas Mercadante serving as CEO.
PursueCare firmographics
Firmographics- Name
- PursueCare
- Legal name
- PAI Delaware Holding Company, Inc.
- Website
- https://pursuecare.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- PursueCare is a privately held telehealth provider founded in 2019 that delivers virtual substance use disorder and co-occurring mental health treatment, including medication-assisted treatment, in-house specialty pharmacy, and FDA-authorized digital therapeutics, to patients across six U.S. states.
- Ownership category
- akta.pro rank
PursueCare industry classification
Industry- Product category
- Telehealth Addiction Treatment Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians (6211), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Health Services (8000), Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
- akta.pro secondary industries
- Integrated Behavioral Health (Collaborative Care) Platforms (HLALAEAC), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where PursueCare is headquartered
LocationHeadquarters
- HQ city
- Middletown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PursueCare business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure
Revenue model
- Telehealth Clinical Services: Revenue from providing telehealth addiction treatment and mental health services billed to insurance (Medicare, Medicaid, private insurance) and patients.
- Prescription Digital Therapeutics (reSET/reSET-O): Subscription-based revenue from FDA-authorized digital therapeutic apps. Standard 12-week subscription costs $90.00, with financial hardship rebate program available for reduced or free access.
- Pharmacy Services (PursueCareRx): Revenue from in-house specialty pharmacy dispensing medications for addiction treatment including Suboxone, Sublocade, and Brixadi. Accepts Medicaid, Medicare, and major insurances.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | reSET/reSET-O 12-week subscription at $90.00 |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
PursueCare product offering
Product offeringCore offering
PursueCare provides telehealth-based substance use disorder and co-occurring mental health treatment through a mobile app and clinical platform. Core services include same-day virtual admissions, medication-assisted treatment (Suboxone, Naltrexone, buprenorphine), counseling/therapy, and FDA-authorized prescription digital therapeutics (reSET and reSET-O) with integrated in-house specialty pharmacy (PursueCareRx) for direct medication delivery.
Product overview
PursueCare operates as a technology-enabled telehealth addiction treatment provider offering a unified platform combining virtual clinical care, medication-assisted treatment, and prescription digital therapeutics. The core offering is the PursueCare Telehealth Platform and mobile app, which provides access to clinicians, counselors, case managers, and psychiatrists for addiction and mental health treatment. The platform integrates an in-house pharmacy (PursueCareRx) for medication dispensing and prescription digital therapeutics (reSET and reSET-O, acquired from Pear Therapeutics in August 2024) for cognitive behavioral therapy support. Treatment services span alcohol recovery, opioid recovery, stimulant recovery, and Kratom/7-OH treatment, with same-day virtual admissions available.
Differentiator
Problem solved
Functional benefit
Brands
- PursueCareRx: In-house specialty pharmacy providing medications for substance use disorder and mental health conditions, delivering medications directly to patients.
Products and services
- PursueCare Telehealth Platform A telehealth platform providing online addiction and mental health counseling services accessible via mobile app, offering virtual visits with clinicians, counselors, case managers, and psychiatrists for substance use disorder and co-occurring mental health treatment.
- PursueCare Mobile App Mobile application for iOS and Android enabling patients to access telehealth services, connect with care teams, schedule appointments, complete digital therapeutic modules, and manage their addiction treatment from their phone.
- reSET-O Digital Therapeutic
Quantifiable outcome
- 75% patient retention rate vs. industry typical treatment programs
- +3 more outcomes
Companies that use PursueCare
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles2 records
PursueCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
PursueCare partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- OhioHealthcorePursueCare partners with OhioHealth to provide solutions for OhioHealth providers to refer patients for substance use disorder treatment. Referrals can be made via email, phone, or online referral form. OhioHealth providers receive a referral guide and access to the referral portal.
- Operation UnitecoreCollaboration with Operation Unite to provide solutions for treating substance use disorder. PursueCare is a technology-enabled, full-service addiction treatment provider available to patients at home through a smartphone. Partnership results in 74% conversion-into-treatment from point of referral.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
PursueCare competitors and assessment
Company assessmentEmerging players
- Cerebral: Cerebral is a virtual mental health provider offering therapy and medication management for anxiety, depression, and ADHD. It is adjacent to PursueCare's behavioral health segment and competes for the same payer-covered mental health patient pool.
- Talkiatry: Talkiatry is a virtual psychiatry practice providing medication management and psychiatric evaluations. It is adjacent to PursueCare's psychiatry and co-occurring mental health service line, though it does not focus on SUD specifically.
- Brightside Health: Brightside Health is a telehealth platform focused on depression, anxiety, and co-occurring mental health treatment with medication management. It overlaps with PursueCare's psychiatry and co-occurring mental health segment but does not specialize in SUD.
Direct peers
- Ophelia: Ophelia provides telemedicine-based medication-assisted treatment for opioid use disorder. It competes directly with PursueCare in the same OUD/MAT telehealth category with similar payer contracts and clinical staffing models.
- Boulder Care: Boulder Care is a telehealth provider of medication-assisted treatment for opioid and alcohol use disorder, with a multidisciplinary care team. It directly competes with PursueCare in the value-based, payer-contracted SUD telehealth space.
- Bicycle Health: Bicycle Health is a virtual opioid use disorder treatment provider delivering Suboxone-based MAT and behavioral health via telemedicine. It directly competes with PursueCare's opioid recovery program and PursueCareRx pharmacy services.
- Lionrock Recovery: Lionrock Recovery delivers online substance use counseling and treatment via telehealth. It overlaps with PursueCare's core telehealth SUD counseling offering for individual and group therapy.
- Workit Health: Workit Health is a virtual substance use disorder treatment provider offering medication-assisted treatment, counseling, and digital tools. It is PursueCare's closest direct competitor, operating a similar telehealth-first SUD model with insurance billing and same-day admissions.
- Pelago (formerly Quit Genius): Pelago is a digital substance use management platform serving employers and health plans with virtual SUD treatment. It overlaps with PursueCare in employer- and payer-channel SUD care and digital therapeutic delivery.
- Ria Health: Ria Health is a telehealth program for alcohol use disorder combining medication, coaching, and digital tools. It is a direct peer to PursueCare's alcohol recovery services line.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
PursueCare social profiles
Digital presencePursueCare compliance and trust
Trust signalCompliance9 records
PursueCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
PursueCare leadership team
Management profileNumber of profiles
Profiles2 records
PursueCare subsidiaries and ownership
Company hierarchySubsidiaries1 record
PursueCare funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PursueCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PursueCare
What does PursueCare do?
PursueCare provides telehealth-based substance use disorder and co-occurring mental health treatment through a mobile app and clinical platform. Core services include same-day virtual admissions, medication-assisted treatment (Suboxone, Naltrexone, buprenorphine), counseling/therapy, and FDA-authorized prescription digital therapeutics (reSET and reSET-O) with integrated in-house specialty pharmacy (PursueCareRx) for direct medication delivery.
Is PursueCare a public or private company?
PursueCare is a private company. It is classified as venture growth investor backed and is currently operating.
When was PursueCare founded?
PursueCare was founded in 2019. It employs 51 to 100 people.
Where is PursueCare based?
PursueCare is headquartered in Middletown, United States, in the North America region.
How does PursueCare make money?
Three revenue lines are on record. Telehealth Clinical Services are the primary driver. The others are prescription Digital Therapeutics (reSET/reSET-O) and pharmacy Services (PursueCareRx).
Who are PursueCare's main competitors?
Emerging players on record are Cerebral, Talkiatry and Brightside Health. Direct peers are Ophelia, Boulder Care, Bicycle Health, Lionrock Recovery, Workit Health, Pelago (formerly Quit Genius) and Ria Health.
Does PursueCare have an API?
No public API is recorded for PursueCare.
What industry is PursueCare in?
PursueCare's product category is Telehealth Addiction Treatment Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms, with a secondary code of HLALAEAC, Integrated Behavioral Health (Collaborative Care) Platforms. Its NAICS code is 621420 and its SIC code is 8000.